351 related articles for article (PubMed ID: 31418125)
1. The Tumor Microenvironment of Pediatric Sarcoma: Mesenchymal Mechanisms Regulating Cell Migration and Metastasis.
Ehnman M; Chaabane W; Haglund F; Tsagkozis P
Curr Oncol Rep; 2019 Aug; 21(10):90. PubMed ID: 31418125
[TBL] [Abstract][Full Text] [Related]
2. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
3. Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis.
Mao XY; Li QQ; Gao YF; Zhou HH; Liu ZQ; Jin WL
Cancer Lett; 2016 Oct; 381(1):133-7. PubMed ID: 27490999
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?
Sannino G; Marchetto A; Kirchner T; Grünewald TGP
Cancer Res; 2017 Sep; 77(17):4556-4561. PubMed ID: 28811330
[TBL] [Abstract][Full Text] [Related]
5. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
6. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
8. Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?
Pennacchioli E; Tosti G; Barberis M; De Pas TM; Verrecchia F; Menicanti C; Testori A; Mazzarol G
Clin Exp Metastasis; 2012 Oct; 29(7):757-73. PubMed ID: 22699363
[TBL] [Abstract][Full Text] [Related]
9. MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues.
Gonzalez-Molina J; Gramolelli S; Liao Z; Carlson JW; Ojala PM; Lehti K
Cells; 2019 Aug; 8(9):. PubMed ID: 31466240
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
Jung HY; Fattet L; Yang J
Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
[TBL] [Abstract][Full Text] [Related]
11. Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma.
Molina ER; Chim LK; Barrios S; Ludwig JA; Mikos AG
Tissue Eng Part B Rev; 2020 Jun; 26(3):249-271. PubMed ID: 32057288
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
13. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2.
Somarelli JA; Shetler S; Jolly MK; Wang X; Bartholf Dewitt S; Hish AJ; Gilja S; Eward WC; Ware KE; Levine H; Armstrong AJ; Garcia-Blanco MA
Mol Cell Biol; 2016 Oct; 36(19):2503-13. PubMed ID: 27402864
[TBL] [Abstract][Full Text] [Related]
17. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
18. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
20. EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.
Kahlert UD; Joseph JV; Kruyt FAE
Mol Oncol; 2017 Jul; 11(7):860-877. PubMed ID: 28556516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]